Inventor · disambiguated record
Debra Odink
Also filed as: ODINK DEBRA · ODINK DEBRA A · ODINK DEBRA ALIDA
3 granted patents·9 pending applications·15 citations·filing 2001–2023
68Inventor score
Top patents by PatentIndex Score
12 records- 0194US11738086B2Methods of using buffered formulations of exendin (9-39)EIGER BIOPHARMACEUTICALS INC·Filed 2021·Granted Aug 29, 2023·5 cites·26 claims
- 0289US11020484B2Buffered formulations of exendin (9-39)EIGER BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 1, 2021·8 cites·30 claims
- 0379US2024042035A1Buffered Formulations Of Exendin (9-39)EIGER BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0466US8048880B2Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapiesANTHERA PHARMACEUTICALS INC·Filed 2008·Granted Nov 1, 2011·2 cites·30 claims
- 0550US2004170689A1Stabilized formulations comprising hydrolytically unstable compositionsFiled 2004·Application pending·0 cites
- 0644US2005065141A1Carbapenems useful in treating and preventing pulmonary infections, pharmaceutical compositions thereof and modes of administration thereofFiled 2004·Application pending·0 cites
- 0739US2010160361A1Treatment of major adverse cardiac events and acute coronary syndrome using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapiesHISLOP COLIN·Filed 2009·Application pending·0 cites
- 0835US2002086057A1Stabilized fromulations comprising hydrolytically unstable compositionsFiled 2001·Application pending·0 cites
- 0931US2011269786A1Treatment of major adverse cardiac events and acute coronary syndrome in diabetic patients using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapiesHISLOP COLIN·Filed 2011·Application pending·0 cites
- 1030US2011301202A1Spla2 inhibitor conjugate compounds and methods of useHISLOP COLIN·Filed 2011·Application pending·0 cites
- 1129US2011207710A1Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapiesTRIAS JOAQUIM·Filed 2011·Application pending·0 cites
- 1219US2010204249A1Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemiaHISLOP COLIN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Debra Odink files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →